Back to search

United States· US:0641-6277_f857cc8d-c0db-4dad-81ed-d863d2d206ae

Neostigmine Methylsulfate

A medicinal product containing neostigmine methylsulfate, registered in United States by Hikma Pharmaceuticals USA Inc..

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedNeostigmine MethylsulfateATC—REGISTER NO.US:0641-6277_f857cc8d…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
NEOSTIGMINE METHYLSULFATE
Manufacturer
Hikma Pharmaceuticals USA Inc.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    0641627710
    10 VIAL, MULTI-DOSE in 1 CARTON (0641-6277-10) / 10 mL in 1 VIAL, MULTI-DOSE (0641-6277-01)
  • ndc11
    0641-6277-10

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Neostigmine methylsulfate in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All neostigmine methylsulfate products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

  • Austria · Neostig, Normastigmin
  • Cyprus · Neostigmine Cooper
  • Czechia · Syntostigmin
  • Germany · Neostig, Neostigmin Panpharma
  • Spain · Neostigmina Braun
  • France · Néostigmine Renaudin, Prostigmine
  • United Kingdom (Northern Ireland) · Neostigmine Methylsulfate Bp Hameln Pharma
  • Greece · Neostigmine Cooper
  • Croatia · Neostigmin Panpharma
  • Hungary · Neostigmine Kalceks, Stigmosan
  • Latvia · Neostigmine Kalceks
  • Netherlands · Neostigminemethylsulfaat Cf, Prostigmin
  • Poland · Polstigminum
  • Portugal · Neostigmina Braun
  • Romania · Miostin
  • Sweden · Neostigmin Unimedic Pharma Ab
  • Slovakia · Syntostigmin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/df7ab270-1fa3-47be-badb-04ee29df4147
GET /v1/drugs/df7ab270-1fa3-47be-badb-04ee29df4147?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "1",
  "substance": "NEOSTIGMINE METHYLSULFATE",
  "productndc": "0641-6277",
  "dosage_form": "INJECTION",
  "dea_schedule": null,
  "strength_unit": "mg/mL",
  "application_number": "ANDA207042",
  "marketing_category": "ANDA"
}

See everything about neostigmine methylsulfate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.